Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 1 2

Status

Completed 11Unknown 4Recruiting 3Active not recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Hot Flashes 1Breast Neoplasms 1

Interventions

Carboplatin 107Cisplatin 98Paclitaxel 77pembrolizumab 70Gemcitabine 59Pemetrexed 50Cyclophosphamide 46Dexamethasone 45durvalumab 44Docetaxel 44Capecitabine 44Radiotherapy 40Nivolumab 37Lenalidomide 37Specimen Handling 36Doxorubicin 36Rituximab 34Oxaliplatin 34Bevacizumab 33Magnetic Resonance Spectroscopy 32Fluorouracil 32atezolizumab 29Etoposide 29Vincristine 26Radiation 26Leucovorin 26Letrozole 24Bortezomib 24Fulvestrant 23Prednisone 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Aromatase Inhibitors × Clear all
NCT06440967 2026-04-06

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

Astellas Pharma Inc

Phase 3 Active not recruiting
984 enrolled

Hot Flashes

NCT02338310 2020-02-17

POETIC

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting
4,486 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡